United Kingdom Updates
United Kingdom: MHRA Issues Guidance for Clinical Trials Post-Brexit Transition Period
Sep 1, 2020 - On September 1, 2020, the United Kingdom (UK) Medicines and Healthcare products Regulatory Agency (MHRA) issued the following guidance documents related to clinical trials after the Brexit transition period ends on December 31, 2020:
Registration of clinical trials for investigational ...
UK Profile Updated in ClinRegs
Mar 20, 2020 - The United Kingdom (UK) profile in ClinRegs has been reviewed and updated with the following:
Updated information on the UK’s withdrawal from the European Union and its impact on clinical research (See Scope of Assessment)
Updated information on electronic communication ...
United Kingdom: MHRA Issues Guidance for Clinical Trials Impacted by COVID-19
Mar 18, 2020 - On March 12, 2020, the UK Medicines and Healthcare Products Regulatory Agency (MHRA) issued Advice for Management of Clinical Trials in relation to Coronavirus that provides information related to protocol deviation, sites, and participant safety.
Select the checkbox to filter the updates